High dose rate 192Ir afterloading brachytherapy for cancer of the vagina

British Journal of Radiology

Volumn 76, Issue 910, 2003, Pages 719-725

  Kushner, D M ^a   Fleming, P A ^b   Kennedy, A W ^b   Wilkinson, D A ^b   Lee, E ^c   Saffle, P A ^b  

^a University of Wisconsin Health   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c 21ST CENTURY ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRIDIUM 192;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; COST EFFECTIVENESS ANALYSIS; DERMATITIS; DIARRHEA; DYSURIA; ENTERITIS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL PERSONNEL; HUMAN; HYDRONEPHROSIS; LONG TERM CARE; MELANOMA; NECROSIS; PATIENT ATTITUDE; RADIATION BEAM; RADIATION DEPTH DOSE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; SMALL CELL CARCINOMA; SMALL INTESTINE OBSTRUCTION; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; URETER OBSTRUCTION; VAGINA CANCER; VAGINA DISCHARGE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SMALL CELL; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRIDIUM RADIOISOTOPES; LINEAR MODELS; MELANOMA; MIDDLE AGED; TREATMENT OUTCOME; VAGINAL NEOPLASMS;

EID: 0142028253     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/15634046     Document Type: Article

References (24)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer Statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Delouche G, Gest J. Treatment of uterine cancer by Curietron. Nouv Presse Med 1974;3:597-600.
3. Fournier DV, Senf W, Kuttig H, Kubli F. Improvement of gynecologic radium therapy through the afterloading method using cesium 137. Strahlentherapie 1976;151:195-207.
4. Hope-Stone HF, Klevenhagen SC, Mantell BS, Morgan WY, Scholnick SA. Use of the Curietron at the London Hospital. Clin Radiol 1981;32:17-23.
5. Joslin CA, Smith CW, Mallik A. The treatment of cervix cancer using high activity 60 Co sources. Br J Radiol 1972;45:257-70.
6. Fleming P, Syed N, Neblett D, Puthawala A, George FW, Townsend D. Description of an afterloading Ir-192 interstitial-intracavitary technique in the treatment of carcinoma of the vagina. Obstet Gynecol 1980;55:525-30.
7. Thames H, Hendry J. Fractionation in Radiotherapy. London, UK: Taylor & Francis, 1987.
8. Fowler J. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
9. Dale R. The use of small fraction numbers in high dose-rate gynaecological afterloading: Some radiobiological considerations. Br J Radiol 1990;63:290-4.
10. Utley J, Von Essen C, Horn R, Moeller J. High-dose-rate afterloading brachytherapy in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1984;10:2259-63.
11. Stock RG, Mychalczak B, Armstrong JG, Curtin JP, Harrison LB. The importance of brachytherapy techniques in the management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys 1992;24:747-53.
12. Chyle V, Zagars GK, Wheeler JA, Wharton JT, Delclos L. Definitive radiotherapy for carcinoma of the vagina: Outcome and prognostic factors. Int J Radiat Oncol Biol Phys 1996;35:891-905.
13. Perez CA, Grigsby PW, Garipagaoglu M, Mutch DG, Lockett MA. Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 1999;44:37-45.
14. Gupta AK, Vicini FA, Frazier AJ, Barth-Jones DC, Edmundson GK, Mele E, et al. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies. Int J Radiat Oncol Biol Phys 1999;43:1055-60.
15. Nag S, Martinez-Monge R, Selman AE, Copeland LJ. Interstitial brachytherapy in the management of primary carcinoma of the cervix and vagina. Gynecol Oncol 1998;70:27-32.
16. MacLeod C, Fowler A, Dalrymple C, Atkinson K, Elliott P, Carter J. High-dose-rate brachytherapy in the management of high-grade intraepithelial neoplasia of the vagina. Gynecol Oncol 1997;65:74-7.
17. Ogino I, Kitamura T, Okajima H, Matsubara S. High-dose-rate intracavitary brachytherapy in the management of cervical and vaginal intraepithelial neoplasia. Int J Radiat Oncol Biol Phys 1998;40:881-7.
18. Xiang E W, Shu-Mo C, Ya-Qin D, Ke W. Treatment of late recurrent vaginal malignancy after initial radiotherapy for carcinoma of the cervix: An analysis of 73 cases. Gynecol Oncol 1998;69:125-9.
19. Ito H, Shigemantsu N, Kawada T, Kubo A, Isobe K, Hara R, et al. Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy. Gynecol Oncol 1997;67:154-61.
20. Nanavati PJ, Fanning J, Hilgers RD, Hallstrom J, Crawford D. High-dose-rate brachytherapy in primary Stage I and II vaginal cancer. Gynecol Oncol 1993;51:67-71.
21. Kucera H, Mock U, Knocke TH, Kucera E, Potter R. Radiotherapy alone for invasive vaginal cancer: Outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy. Acta Obstet Gynecol Scand 2001;80:355-60.
22. Dusenbery KE, Carson LF, Potish RA. Perioperative morbidity and mortality of gynecologic brachytherapy. Cancer 1991;67:2786-90.
23. Lee WR, Marcus RB, Sombeck MD, Mendenhall WM, Morgan LS, Freeman DE, et al. Radiotherapy alone for carcinoma of the vagina: The importance of overall treatment time. Int J Radiat Oncol Biol Phys 1994;29:983-8.
24. Demanes DJ, Rege S, Rodriquez RR, Schutz KL, Altieri GA, Wong T. The use and advantages of a multichannel vaginal cylinder in high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1999;44:211-9.